Shining on Major News: Aduro BioTech (NASDAQ:ADRO), Methes Energies International (NASDAQ:MEIL), Acadia Realty Trust (NYSE:AKR), Enanta Pharmaceuticals (NASDAQ:ENTA), Penn National Gaming (NASDAQ:PENN)

On Wednesday shares of Aduro BioTech Inc (NASDAQ:ADRO) closed at $42.00. Aduro Biotech, Inc. (Nasdaq:ADRO) announced the pricing of its initial public offering of 7,000,000 shares of common stock at a price to the public of $17.00 per share. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discount.

Methes Energies International Ltd. (NASDAQ:MEIL) in last trading activity increased 19.05% to close at $1.25. Company weekly performance is 56.25% while its quarterly performance stands at 4.17%. Methes Energies International Ltd. (NASDAQ:MEIL) is -71.26% away from its 52 week high. Methes Energies International Ltd. (NASDAQ:MEIL) announced that it has received CDN$250,000 as initial payment for the sale of a Denami 600 biodiesel processor and a PP-MEC pretreatment system to be installed in Havelock, Ontario, Canada.

On last trading day Acadia Realty Trust (NYSE:AKR) fell -0.73% to close at $32.86. Its volatility for the week is 1.66% while volatility for the month is 1.66%. AKR’s sales growth for past 5 years was 7.70% and its EPS growth for past 5 years was 10.80%. Acadia Realty Trust (NYSE:AKR) monthly performance is -3.86%. Acadia Realty Trust (NYSE:AKR) is continuing its Upper East Side push with the purchase of a five-story commercial building at 801 Madison Avenue for $33 million, according to property records filed with the city today.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has 4.50% insider ownership while its institutional ownership stands at 77.80%. In last trading activity company’s stock closed at $36.03. Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) announced on 8 April, abstracts of research on regimens containing either one of Enanta’s two protease inhibitors for hepatitis C virus (HCV) identified and developed in its ongoing collaboration with AbbVie have been accepted for presentation at The International Liver Congress (ILC) which is the 50th Annual Meeting of the European Association for the Study of the Liver (EASL) taking place in Vienna April 22-26 2015.

On last trading day Penn National Gaming Inc. (NASDAQ:PENN) increased 3.24% to close at $15.30. Its volatility for the week is 3.05% while volatility for the month is 3.31%. PENN’s sales growth for past 5 years was 1.80% and its EPS growth for past 5 years was 2.60%. Penn National Gaming Inc. (NASDAQ:PENN) monthly performance is -6.48%.Six state legislators from Lawrence, Beaver and Mercer counties have formally requested that Attorney General Kathleen Kane launch an investigation of Penn National Gaming Inc. (NASDAQ:PENN)’s decision to back out of an agreement to manage a proposed racetrack-casino project in Lawrence County.

Leave a Reply

Your email address will not be published. Required fields are marked *